| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |